Advantage Austria Show navigation

Baxter Enlarges Viennese Site

May 29, 2012

Foundation laid for new production facility with Vienna Mayor Dr. Michael Häupl

The U.S. pharmaceutical group makes investments of 30 million EUR in Vienna. The start of operation of a new production facility is planned in 2014.

In May Baxter initiated the construction of a new production facility in Vienna. By 2014, Baxter plans to produce biological glue for medical purposes. The investment volume reaches € 30m, Baxter said. The production site will be started up by the end of 2014.

In 2011, Baxter made investments of 47 million EUR in Austria. In 2012 the investment volume should total 100 million EUR The U.S. pharmaceutical group currently employs 4,100 persons in Austria, making 22 products for 100 countries. In 2011, the staff number rose by 116 employees. Since 1996, Baxter has been operating in Austria after Immuno AG had been taken over.

print
©©ADVANTAGE AUSTRIA